Navigation Links
Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
Date:5/21/2012

Nicollet Mall, J12S03, Minneapolis, MN 55402 or by telephone at 800-747-3924 or by email at prospectus@pjc.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Arena Pharmaceuticals® and Arena® are registered service marks of the company.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's anticipated use of proceeds from the offering, its focus, its research and development programs, and its ability to discover and develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review is uncertain and Arena's applications for regulatory approval of lorcaserin may not be reviewed when or as anticipated; the timing, results, influence and other impact of FDA advisory committee meetings relating to lorcaserin and other drug candidates; the FDA may not comp
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Array BioPharma ... results for the fourth quarter and full ... conference call to discuss those results on ... Executive Officer and Michael Carruthers , ... Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern ...
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2
... a good night,s sleep to overall health have long been ... gender and weight management play in overall sleep patterns.  The ... Sleep and BMI , was presented during a poster session ... week. (Photo: http://photos.prnewswire.com/prnh/20111004/NE78562 ) ...
... YORK, Oct. 4, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0177915/US-Market-for-Neurological-Devices-2010.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment In 2009, ... valued at just over $2.2 billion, an ...
Cached Medicine Technology:Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 3U.S. Market for Neurological Devices 2010 2U.S. Market for Neurological Devices 2010 3U.S. Market for Neurological Devices 2010 4U.S. Market for Neurological Devices 2010 5U.S. Market for Neurological Devices 2010 6U.S. Market for Neurological Devices 2010 7U.S. Market for Neurological Devices 2010 8U.S. Market for Neurological Devices 2010 9U.S. Market for Neurological Devices 2010 10U.S. Market for Neurological Devices 2010 11U.S. Market for Neurological Devices 2010 12U.S. Market for Neurological Devices 2010 13U.S. Market for Neurological Devices 2010 14U.S. Market for Neurological Devices 2010 15U.S. Market for Neurological Devices 2010 16U.S. Market for Neurological Devices 2010 17
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... appear to have a slightly increased risk of potentially ... Swedish researchers report. Doctors have previously suspected that ... raised risk of deep vein thrombosis and pulmonary embolism, ... veins, the researchers noted in background information. This ...
(Date:7/28/2014)... 28, 2014 The Oneida Indian Nation ... incredible field of accompanying PGA TOUR players will be ... analyst Notah Begay III for the seventh annual Notah ... Stone Resort Casino ’s Atunyote® Golf Club on Wednesday, ... Woods, Jason Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera ...
(Date:7/28/2014)... mobile devices are on the cusp of revolutionizing health ... providing everything from cardiac measurements to sonograms. , While ... and control costs, several health law experts say in ... (NEJM) report that more oversight is needed by the ... confidence and safety. Out of some 100,000 mHealth apps ...
(Date:7/28/2014)... New York (PRWEB) July 28, 2014 ... edition of “Organic Living” on March 12th, a campaign ... an organic lifestyle. In partnership with industry leader ... over 100 Certified Organic teas, the campaign provides readers ... recent years that continues to propel the industry forward ...
(Date:7/28/2014)... July 28, 2014 Irresistible infants have met their ... of Comfort. The online gifting company specializes in homemade chicken noodle ... The New Baby package starts with home-from-the-hospital essentials every new parent ... 6 rolls , 6 cookies , ... The soup is ready to heat and eat upon delivery, so ...
Breaking Medicine News(10 mins):Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... oncologist and Craig Greven, Vitreoretinal surgeon, Wake Forest University ... with radiation therapy. Uveal malignant melanoma// is a rare ... people per year in the United States. It is ... seen in nonwhite races. The results of the study ...
... was first initiated in India to help overcome Vitamin ... in India, it now lags behind African and neighbouring ... report.,The report entitled "Controlling Vitamin and Mineral Deficiencies in ... the largest percentage as well as the largest absolute ...
... Alzheimer’s disease (AD), characterized by progressive memory loss, decline ... a major threat to ageing population.// ,A ... reviews the different strategies in drug discovery. Hong-Yu Zhang, ... of the present one-drug-one-target strategy in drug discovery is ...
... levels of low density lipoprotein (LDL) (also called bad ... are taking statins.// ,Those taking high doses of ... milligrams/deciliters to as low as 40 mg/dL. No one ... P. Cannon, a cardiologist at Brigham and Women's Hospital ...
... to a diverse range of insults, such as surgery, ... range of cell types of the immune system, creating ... inflammatory response, although essential for fighting infection, may damage ... mediators, cytokines and lipid mediators being the key mediators. ...
... Singh and Union Health Minister Anbumani Ramadoss are to convene ... problem of bird flu epidemic. //Awareness of bird flu and ... to the Western countries. The World Health Organization has sent ... if there are any possible flu attack. Dr. Anbumani said ...
Cached Medicine News:Health News:Radiation therapy effective against Eye cancer 2Health News:Vitamin A supplementation inadequate in India: Need for effective strategies 2Health News:The ideal composition of intravenous lipid emulsion 2
Triad Plus PVP-I Scrub Winged Sponges...
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... Performance Panel consists of plasma specimens with ... for antibodies to the Hepatitis C Virus. ... manufacturers and diagnostic laboratories to evaluate their ... test systems are included for comparative analysis ...
Medicine Products: